• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于核心针活检的组织病理学特征和钙化评估对乳腺非典型导管增生的诊断升级。

Diagnostic upgrade of atypical ductal hyperplasia of the breast based on evaluation of histopathological features and calcification on core needle biopsy.

机构信息

Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.

Department of Pathology, Shenzhen People's Hospital, Shenzhen, China.

出版信息

Histopathology. 2019 Sep;75(3):320-328. doi: 10.1111/his.13881. Epub 2019 Jul 16.

DOI:10.1111/his.13881
PMID:31013355
Abstract

AIMS

Atypical ductal hyperplasia (ADH) of breast is increasingly diagnosed in core needle biopsy (CNB). As higher-grade lesions were found in the excision in a substantial proportion of ADH on CNB, factors predicting risk of subsequent upgrade are clinically significant. This study aims to investigate relevant histopathological factors in CNB that could predict diagnostic upgrade at excision.

METHODS AND RESULTS

One hundred and forty-three cases of CNB with paired subsequent excision were evaluated for multiple clinicopathological parameters related to CNB sampling, ADH morphology, calcification and other co-existing histological features, and which of these parameters were associated with diagnostic upgrade at subsequent excisions were determined. Forty-eight cases (34.3%) were upgraded to malignancy, including 15 invasive cancers and 33 ductal carcinomas in situ (DCIS). An increased tissue area occupied by ADH (P = 0.026), a higher number of ADH foci (P = 0.004), the presence of solid pattern (P = 0.037) and older age (P = 0.012) were positively associated with upgrade, while negative associations were found with the presence of micropapillary pattern (P = 0.025), co-existing columnar cell lesions (CCL) (P = 0.001) and the presence of calcifications (P = 0.009). Multivariate logistic regression analysis showed that the number of ADH foci (HR = 2.810, P = 0.013) was an independent positive predictor, while co-existing CCL (HR = 0.391, P = 0.013) was an independent negative predictor for upgrade.

CONCLUSIONS

Patients with ADH in CNB showing the presence of co-existing CCL and a lower number of ADH foci have a lower risk of disease upgrade at excision, and are potential candidates for observation-only management.

摘要

目的

乳腺非典型导管增生(ADH)在核心针活检(CNB)中越来越多地被诊断出来。由于在相当一部分 ADH 的 CNB 切除标本中发现了高级别病变,因此预测后续升级风险的因素在临床上具有重要意义。本研究旨在探讨 CNB 中与 ADH 相关的组织病理学因素,这些因素可预测切除时的诊断升级。

方法和结果

对 143 例 CNB 伴随后续切除的病例进行了评估,这些病例涉及与 CNB 取样、ADH 形态、钙化和其他共存组织学特征相关的多个临床病理参数,确定了这些参数中哪些与后续切除时的诊断升级有关。48 例(34.3%)升级为恶性肿瘤,包括 15 例浸润性癌和 33 例导管原位癌(DCIS)。ADH 所占组织面积增加(P=0.026)、ADH 灶数量增加(P=0.004)、存在实体模式(P=0.037)和年龄较大(P=0.012)与升级呈正相关,而存在微乳头状模式(P=0.025)、共存柱状细胞病变(CCL)(P=0.001)和存在钙化(P=0.009)则与升级呈负相关。多变量逻辑回归分析显示,ADH 灶数量(HR=2.810,P=0.013)是独立的阳性预测因子,而共存 CCL(HR=0.391,P=0.013)是升级的独立阴性预测因子。

结论

在 CNB 中表现为共存 CCL 和 ADH 灶数量较少的 ADH 患者,在切除时发生疾病升级的风险较低,是仅观察管理的潜在候选者。

相似文献

1
Diagnostic upgrade of atypical ductal hyperplasia of the breast based on evaluation of histopathological features and calcification on core needle biopsy.基于核心针活检的组织病理学特征和钙化评估对乳腺非典型导管增生的诊断升级。
Histopathology. 2019 Sep;75(3):320-328. doi: 10.1111/his.13881. Epub 2019 Jul 16.
2
Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.在粗针活检中,与导管原位癌(DCIS)相邻的非典型导管增生比传统的非典型导管增生升级风险更高。
Breast Cancer Res Treat. 2020 Dec;184(3):873-880. doi: 10.1007/s10549-020-05890-1. Epub 2020 Aug 28.
3
Atypical ductal hyperplasia on core needle biopsy: Development of a predictive model stratifying carcinoma upgrade risk on excision.核心针活检中的非典型导管增生:建立预测模型,对切除时的癌升级风险进行分层。
Breast J. 2019 Jan;25(1):56-61. doi: 10.1111/tbj.13155. Epub 2018 Nov 20.
4
Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature.影响核心针活检诊断不典型导管增生的因素分析——一项 10 年回顾性研究及文献复习。
Int J Surg. 2018 Jan;49:27-31. doi: 10.1016/j.ijsu.2017.11.005. Epub 2017 Nov 13.
5
Upgrade rate of intraductal papilloma diagnosed on core needle biopsy in a single institution.单中心经皮穿刺活检诊断的导管内乳头状瘤升级率。
Hum Pathol. 2021 Apr;110:43-49. doi: 10.1016/j.humpath.2020.10.012. Epub 2020 Nov 5.
6
Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens.非典型导管增生及低估风险:组织取样方法、多灶性和相关钙化显著影响基于后续手术标本的诊断升级率。
Breast Cancer. 2019 Jul;26(4):452-458. doi: 10.1007/s12282-018-00943-2. Epub 2018 Dec 27.
7
Radiologic and Pathologic Features Associated With Upgrade of Atypical Ductal Hyperplasia at Surgical Excision.在外科切除时,与非典型导管增生升级相关的放射学和病理学特征。
Acad Radiol. 2019 Jul;26(7):893-899. doi: 10.1016/j.acra.2018.09.010. Epub 2018 Oct 12.
8
Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?粗针活检发现小叶原位癌或非典型小叶增生:是否需要切除活检?
Radiology. 2004 Jun;231(3):813-9. doi: 10.1148/radiol.2313030874. Epub 2004 Apr 22.
9
Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.乳腺粗针活检标本中存在的非典型导管增生的范围和组织学模式可预测后续切除术中的导管原位癌。
Am J Clin Pathol. 2009 Jan;131(1):112-21. doi: 10.1309/AJCPGHEJ2R8UYFGP.
10
Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.多变量模型识别在核心针活检诊断为非典型导管增生后癌症升级风险低的女性。
Breast Cancer Res Treat. 2017 Jul;164(2):295-304. doi: 10.1007/s10549-017-4253-1. Epub 2017 May 4.

引用本文的文献

1
Atypical ductal hyperplasia diagnosed by US-guided core needle biopsy: clinical, pathological and US features associated with upgrading to malignancy.超声引导下粗针穿刺活检诊断的非典型导管增生:与升级为恶性肿瘤相关的临床、病理及超声特征
BMC Med Imaging. 2025 May 19;25(1):168. doi: 10.1186/s12880-025-01707-z.
2
Contrast-enhanced ultrasound to predict malignant upgrading of atypical ductal hyperplasia.超声造影预测不典型导管增生的恶性升级。
Breast Cancer Res. 2024 Feb 12;26(1):27. doi: 10.1186/s13058-024-01772-2.
3
Is Surgical Excision of Focal Atypical Ductal Hyperplasia Warranted? Experience at a Tertiary Care Center.
是否需要手术切除局灶性非典型导管增生?一家三级保健中心的经验。
Ann Surg Oncol. 2023 Jul;30(7):4087-4094. doi: 10.1245/s10434-023-13319-4. Epub 2023 Mar 11.
4
Identifying women with increased risk of breast cancer and implementing risk-reducing strategies and supplemental imaging.识别具有乳腺癌风险增加的女性,并实施降低风险策略和补充性影像学检查。
Breast Cancer. 2022 Jan;29(1):19-29. doi: 10.1007/s12282-021-01298-x. Epub 2021 Oct 19.
5
Atypical Ductal Hyperplasia after Vacuum-Assisted Breast Biopsy: Can We Reduce the Upgrade to Breast Cancer to an Acceptable Rate?真空辅助乳腺活检后的非典型导管增生:我们能否将升级为乳腺癌的比例降低到可接受的水平?
Diagnostics (Basel). 2021 Jun 19;11(6):1120. doi: 10.3390/diagnostics11061120.
6
Development and Validation of a Simple-to-Use Nomogram for Predicting the Upgrade of Atypical Ductal Hyperplasia on Core Needle Biopsy in Ultrasound-Detected Breast Lesions.一种用于预测超声检测乳腺病变粗针活检中非典型导管增生升级的简易列线图的开发与验证
Front Oncol. 2021 Mar 31;10:609841. doi: 10.3389/fonc.2020.609841. eCollection 2020.
7
Pure Ductal Carcinoma In Situ of the Breast: Analysis of 270 Consecutive Patients Treated in a 9-Year Period.乳腺单纯导管原位癌:9年期间连续治疗的270例患者分析
Cancers (Basel). 2021 Jan 23;13(3):431. doi: 10.3390/cancers13030431.
8
Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.在学术机构中对核心活检诊断的高危乳腺病变的管理,以及前瞻性高危乳腺病变会议的经验。
Breast Cancer Res Treat. 2021 Feb;185(3):573-581. doi: 10.1007/s10549-020-05977-9. Epub 2020 Oct 17.
9
Performance of a clinical and imaging-based multivariate model as decision support tool to help save unnecessary surgeries for high-risk breast lesions.基于临床和影像学的多变量模型作为决策支持工具的性能,有助于避免高危乳腺病变的不必要手术。
Breast Cancer Res Treat. 2021 Jan;185(2):479-494. doi: 10.1007/s10549-020-05947-1. Epub 2020 Oct 3.
10
Prospective Analysis Using a Novel CNN Algorithm to Distinguish Atypical Ductal Hyperplasia From Ductal Carcinoma in Situ in Breast.利用新型卷积神经网络算法对乳腺非典型性导管增生和导管原位癌进行前瞻性分析。
Clin Breast Cancer. 2020 Dec;20(6):e757-e760. doi: 10.1016/j.clbc.2020.06.001. Epub 2020 Jun 7.